EcoDrugPlus

Ensembl ID : ENSNFUG00015023685
Gene Symbol: -
Cross references: -
966 Possible Orthologues:

Ensembl ID : ENSNFUG00015023540
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSNFUG00015012325
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSNFUG00015000658
Gene Symbol: -
Cross references: -
185 Possible Orthologues:

Ensembl ID : ENSNFUG00015019465
Gene Symbol: RPS25
1 Cross references
450 Possible Orthologues:

Ensembl ID : ENSNFUG00015001625
Gene Symbol: -
Cross references: -
179 Possible Orthologues:

Ensembl ID : ENSNFUG00015023331
Gene Symbol: -
Cross references: -
181 Possible Orthologues:

Ensembl ID : ENSNFUG00015005347
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Ensembl ID : ENSNFUG00015025106
Gene Symbol: -
Cross references: -
191 Possible Orthologues:

Ensembl ID : ENSNFUG00015012060
Gene Symbol: -
1 Cross references
275 Possible Orthologues:

Ensembl ID : ENSNFUG00015022894
Gene Symbol: -
Cross references: -
191 Possible Orthologues:

Ensembl ID : ENSNFUG00015005730
Gene Symbol: -
Cross references: -
186 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).